STAT Plus: CRISPR’s pioneers reflect on the first gene-editing treatment
Jennifer Doudna, Emmanuelle Charpentier, Feng Zhang, and George Church reflect on the approval of Casgevy, the first CRISPR-based drug.
Read The StoryCRISPR
CRISPR is a gene editing technology that allows scientists to make precise changes to DNA. Here you can learn about the companies developing CRISPR-based treatments, and the tremendous potential in its use.
For the latest CRISPR advances, check out STAT’s searchable CRISPR Trackr.
Key questions (and answers) about the historic approval of a CRISPR-based medicine
To protect chickens from bird flu, researchers try to CRISPR in immunity
STAT Plus: David Liu startup to focus on getting CRISPR therapy to hard-to-reach cells
STAT Plus: After decade-long dispute over CRISPR-Cas9, Editas strikes deal with Vertex to cash in
All Coverage
advertisement
